AngelaJainMD

Oncology • Philadelphia, PA

Assistant Professor

Join to view full profile

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jain's full profile

Already have an account?

Office
333 Cottman Ave
Philadelphia, PA 19111
Phone+1 215-728-6900

Fax+1 215-214-3779
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Temple University HospitalResidency, Internal Medicine, 2007 - 2010
Lewis Katz School of Medicine at Temple UniversityClass of 2007

Certifications & Licensure

PA State Medical License 2007 - 2024
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer Start of enrollment: 2013 Apr 29
Active, not recruiting
Phase 2
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Withdrawn
Phase 1
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma Start of enrollment: 2018 Sep 01
Withdrawn
Phase 2
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer Start of enrollment: 2016 Nov 01
Recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Endometrial Cancer Treatment: Long-Term Engagement Strategies.
Howell, K., Jain, A.> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 1
2 citations
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Matthew Zibelman, Alexander W MacFarlane 4th, Kimberly Costello, Thomas McGowan, John O'Neill, Rutika Kokate, Hossein Borghaei, Crystal S Denlinger, Efrat Dotan, Danie...> ;Nature Communications. 2023 Jul 27
95 citations
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Lee-May Chen, Viola C Chitiyo, Mihaela Cr...> ;Journal of the National Comprehensive Cancer Network. 2022 Sep 1
15 citations
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
Neesha C. Dhani, Hal W. Hirte, Lisa Wang, Julia V. Burnier, Angela Jain, Marcus O. Butler, Stephen Welch, Gini F. Fleming, Jean A. Hurteau, Koji Matsuo, Daniela Matei,...> ;Clinical Cancer Research. 2020 Jun 1
170 citations
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Andrew Berchuck, Jonathan S. Berek, Lee-may Chen, Mihaela C. Cristea, M...> ;Journal of the National Comprehensive Cancer Network. 2019 Aug 1
4 citations
Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous car...
Angela Jain, Michael V. Seiden> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2013 May 16
18 citations
Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location.
Angela Jain, Paula D. Ryan, Michael V. Seiden> ;Journal of the National Comprehensive Cancer Network. 2012 Sep 1
Join now to see all